Guardian Pharmacy Services Inc

Guardian Pharmacy Services Inc(GRDN)股票分析

$39.470

-0.209 (-0.53%)收盤時

Loading chart…
最高
39.860
開盤
39.680
成交量加權均價
39.47
成交量
426.04K
市值
—
最低
39.070
成交金額
16.81M
企業價值/稅息折舊攤銷前利潤(TTM)
32.05

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.

AI 分析 of Guardian Pharmacy Services Inc (GRDN)

持有

Guardian Pharmacy Services Inc is currently a hold. The stock is trading at $39.47, which is below the analyst consensus target of $49.81, indicating potential upside. However, the RSI is at 32.151, suggesting it is oversold, and the stock has seen a 5-day decline of 4.38%. The main risk is the recent performance trend, with a year-to-date change of +33.66% but a 20-day change of -12.27%, indicating volatility.

估值指標

Guardian Pharmacy Services Inc(GRDN)目前預期本益比為 30.21,5 年平均預期本益比為 26.69。

預期本益比

合理
5 年均值 P/E
26.69
目前P/E
30.21
高估
30.52
低估
22.85

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
18.19
目前EV/EBITDA
32.05
高估
23.78
低估
12.61

預期股價營收比

高估
5 年均值 P/S
1.27
目前P/S
1.64
高估
1.55
低估
0.99

持有 GRDN 的大戶

A

Aristotle Capital Boston, LLC

+ 持有GRDN

-1.22%

3個月報酬率

事件時間軸

2026-09-01 (ET)

17:00:00

Guardian Pharmacy Acquires Assets from Nautilus Pharmacy

2026-08-06 (ET)

17:01:00

Raises FY26 Adjusted EBITDA View to $129M-$131M

17:01:00

Guardian Reports Q2 Revenue of $351.8M, Beating Expectations

2026-07-01 (ET)

17:00:00

Guardian Pharmacy Acquires Wellness Concepts to Expand Virginia Operations

2026-06-22 (ET)

17:00:00

Guardian Pharmacy Executive Forbes Retires, Morris to Become COO

資訊

GRDN 常見問題 —— 由 Alphio AI 解答

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.

Guardian Pharmacy Services Inc is currently a hold. The stock is trading at $39.47, which is below the analyst consensus target of $49.81, indicating potential upside. However, the RSI is at 32.151, suggesting it is oversold, and the stock has seen a 5-day decline of 4.38%. The main risk is the recent performance trend, with a year-to-date change of +33.66% but a 20-day change of -12.27%, indicating volatility.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易